1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. North Carolina >
  6. Intarcia Therapeutics Acquires Phoundry Pharmaceuticals

M&A Deal Summary

Intarcia Therapeutics Acquires Phoundry Pharmaceuticals

On September 24, 2015, Intarcia Therapeutics acquired life science company Phoundry Pharmaceuticals

Acquisition Highlights
  • This is Intarcia Therapeutics’ 1st transaction in the Life Science sector.
  • This is Intarcia Therapeutics’ 1st transaction in the United States.
  • This is Intarcia Therapeutics’ 1st transaction in North Carolina.

M&A Deal Summary
Date 2015-09-24
Target Phoundry Pharmaceuticals
Sector Life Science
Buyer(s) Intarcia Therapeutics
Deal Type Add-on Acquisition

Target

Phoundry Pharmaceuticals

Research Triangle Park, North Carolina, United States
Phoundry Pharmaceuticals, Inc. is a bio pharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration and tolerability of drug therapies.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Intarcia Therapeutics

Boston, Massachusetts, United States
Category Company
Sector Life Science
DESCRIPTION

Intarcia Therapeutics is a biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. Intarcia Therapeutics is based in Boston, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal